Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma

par Gao, Jing, Zou, Zhengzhi, Gao, Jing, Zhang, Haifang, Lin, Zhicai, Zhang, Yaya, Luo, Xianyang, Liu, Changhua, Xie, Jingdun, Cai, Chengfu
Publié dans Int J Clin Exp Pathol (2015)

A Suppressor of Cytokine Signaling 1 Antagonist Enhances Antigen-Presenting Capacity and Tumor Cell Antigen-Specific Cytotoxic T Lymphocyte Responses by Human Monocyte-Derived Dend...

par Wang, Yongjun, Wang, Shengyu, Ding, Yuan, Ye, Yanhua, Xu, Yingyi, He, Huixiang, Li, Qiaozhen, Mi, Yanjun, Guo, Chunhua, Lin, Zhicai, Liu, Tao, Zhang, Yaya, Chen, Yuqiang, Yan, Jianghua
Publié 2013

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

par Li, Chenggong, Sun, Yan, Wang, Jing, Tang, Lu, Jiang, Huiwen, Guo, Tao, Liu, Lin, Wu, Yaohui, Ai, Lisha, Xia, Linghui, Wu, Jianjun, Lin, Zhicai, Qian, Qijun, Hu, Yu, Mei, Heng
Publié dans Front Immunol (2021)

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

par Fang, Juemin, Ding, Na, Guo, Xianling, Sun, Yan, Zhang, Zhiwei, Xie, Bailu, Li, Zhong, Wang, Hui, Mao, Wei, Lin, Zhicai, Qin, Fei, Yuan, Min, Chu, Wenqi, Qin, Huanlong, Qian, Qijun, Xu, Qing
Publié dans J Immunother Cancer (2021)